Nortis, a Seattle-area startup founded in 2011 that markets “organ-on-a-chip” technology, has raised $6 million, according to an SEC filing.… Read More
EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based company developing radio frequency energy technology to treat a range of diseases, filed to… Read More
Seagen reported second quarter revenue of $498 million, up 28%, beating analyst expectations. The company also recently reported “positive” early… Read More
Less than two years after its IPO and months after shutting down its once-promising oncology program, Seattle-based Silverback Therapeutics will… Read More
Fred Hutchinson Cancer Center is leveraging Amazon’s machine learning expertise to collaborate on an early-stage clinical trial testing an anti-cancer… Read More
Two COVID-19 vaccines with roots in Seattle cleared major regulatory milestones Wednesday. South Korea approved a shot developed by University… Read More
Three Seattle biotech companies are joining forces to support open-access development of protein folding and design software. The project, called… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
